Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AGRX > SEC Filings for AGRX > Form 8-K on 6-Jul-2016All Recent SEC Filings

Show all filings for AGILE THERAPEUTICS INC

Form 8-K for AGILE THERAPEUTICS INC


6-Jul-2016

Change in Directors or Principal Officers, Other Events, Financial Stateme


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 6, 2016, Agile Therapeutics, Inc. ("Agile" or the "Company") announced the appointment of Renee Selman as the Company's Chief Commercial Officer, effective July 6, 2016 (the "Effective Date"). Ms. Selman will succeed Katie MacFarlane, who has chosen to return to her previous role as an advisor to the Company as managing partner of SmartPharma, LLC., as of the Effective Date.

The Company has entered into an employment agreement with Ms. Selman, substantially on the same terms as included in the Company's form of employment agreement, previously filed as Exhibit 10.1 to the Company's quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2016. The Company also has entered into a consulting agreement with Ms. MacFarlane detailing the terms of her role as an advisor to the Company.



Item 8.01 Other Events

On July 6, 2016, the Company issued a press release announcing that Renee Selman had been appointed as the Company's Chief Commercial Officer and is succeeding Katie MacFarlane who has chosen to return to her previous role as an advisor to the Company. A copy of the press release is attached hereto as Exhibit 99.1.



Item 9.01. Financial Statements and Exhibits.

(d)                 Exhibits.



Exhibit
Number                           Description


99.1 Agile Therapeutics, Inc. Press Release dated July 6, 2016.


  Add AGRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AGRX - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.